Azathioprine and 6‐mercaptopurine for maintenance of remission in ulcerative colitis

Background Maintenance of remission is a major issue in inflammatory bowel disease. In ulcerative colitis, the evidence for the effectiveness of azathioprine and 6‐mercaptopurine for the maintenance of remission is still controversial. Objectives To assess the effectiveness and safety of azathioprin...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cochrane database of systematic reviews 2016-05, Vol.2016 (5), p.CD000478
Hauptverfasser:	Timmer, Antje, Patton, Petrease H, Chande, Nilesh, McDonald, John WD, MacDonald, John K
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Anti-Inflammatory Agents, Non-Steroidal - adverse effects Anti-Inflammatory Agents, Non-Steroidal - therapeutic use Antimetabolites Antimetabolites - adverse effects Antimetabolites - therapeutic use Anti‐Inflammatory Agents, Non‐Steroidal Azathioprine Azathioprine - adverse effects Azathioprine - therapeutic use Azathioprine and 6‐mercaptopurine therapy Colitis, Ulcerative Colitis, Ulcerative - drug therapy Gastroenterology & hepatology Humans Inflammatory bowel disease Maintenance Chemotherapy Maintenance Chemotherapy - methods Medicine General & Introductory Medical Sciences Mercaptopurine Mercaptopurine - adverse effects Mercaptopurine - therapeutic use Mesalamine Mesalamine - therapeutic use Randomized Controlled Trials as Topic Secondary Prevention Sulfasalazine Sulfasalazine - therapeutic use ULCERATIVE COLITIS ‐ MAINTENANCE OF REMISSION
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!